We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

STUDY SHOWS VELCADE® PLUS DOXIL® IMPROVES SURVIVAL IN PREVIOUSLY TREATED PATIENTS WITH MYELOMA
Data Presented at the ASCO Cancer Conference
06.04.07

Be the first to comment

 related articles